Birkett Bernard 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Aug 3, 2022
Insider Transaction Report
Form 4
Birkett Bernard
Sr VP, Chief Financial Officer
Transactions
- Sale
Common Stock
2022-08-02$343.38/sh−1,100$377,723→ 795 total - Sale
Common Stock
2022-08-02$340.50/sh−9,359$3,186,695→ 5,610 total - Sale
Common Stock
2022-08-02$341.97/sh−1,708$584,083→ 3,902 total - Sale
Common Stock
2022-08-02$342.59/sh−2,007$687,574→ 1,895 total
Footnotes (4)
- [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $340.1950 to $340.8100, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $341.2700 to $342.2600, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F3]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $342.28 to $342.93, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F4]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $343.31 to $343.67, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.